Navigation Links
Prolia® (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment
Date:9/17/2011

fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.

Prolia is approved in the European Union (EU) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.

Prolia is approved in the U.S., Canada, Australia and in all 27 EU member states as well as in Norway, Iceland and Liechtenstein. Applications in the rest of the world are pending.

Prolia is administered as a single subcutaneous injection of 60 mg once every six months. For further information on Prolia, including prescribing information and medication guide, please visit: www.prolia.com.  

Important U.S. Safety Information

Prolia is contraindicated in patients with hypocalcemia. Pre-existing hypocalcemia must be corrected prior to initiating Prolia. Hypocalcemia may worsen, especially in patients with severe renal impairment. All patients should be adequately supplemented with calcium and vitamin D. Patients receiving Prolia should not receive XGEVA® (denosumab), as both Prolia and XGEVA contain the same active ingredient, denosumab.

In the Phase 3 pivotal study, serious infections leading to hospitalizations were reported more frequently in the Prolia-treated patient group. Serious skin infections, as well as infections of the abdomen, urinary tract and ear, were more frequent in patients treated with Prolia. Patients should be advised to seek prompt medical attention if they develop signs or symptoms of severe infection, including cellulitis. Endocarditis was reported more frequently in the Prolia-treated patient group. Epidermal and dermal adverse events such as dermatitis, rashes and eczema have been reported. Discontinuation of Prolia should be considered if severe symptoms develop.

Prolia resulted
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate
2. Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial
3. XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
4. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
5. Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer
6. The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma
7. XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
8. Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
9. Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
10. Vantage Health Announces That All of Its Required Tanzanian Registrations, Permits and Licenses Have Been Formally Issued, Simultaneous With Official Notification That Its Application for Phase One Evaluation of Its HIV Screening Test Kits Has Been
11. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... , 24 novembre 2014  Surgical Theater ... tecnologia sarà esposta durante l,apertura in data ... d,Europa, ossia la Fondazione IRCCS Istituto Neurologico ... Planner (SRP) (strumento di pianificazione chirurgica) e ... navigazione chirurgica avanzata) saranno presentati in occasione ...
(Date:11/23/2014)...  Aurobindo Pharma USA is ... mg 100-count bottles to the consumer level. The product ... Empty capsules could result in missed dose(s) ... range from no effect, short term reduction in efficacy, ... seizures) that could be life-threatening. Aurobindo Pharma ...
(Date:11/22/2014)... , 21 de noviembre de 2014  BioClinica®, ... clínicos externalizados y tecnologías eClinical, ha indicado un ... ,seguimiento inteligente, para el seguimiento basado en el ... amplía el concepto del seguimiento basado en el ... las visitas de seguimiento o cambio de los ...
Breaking Medicine Technology:La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 2La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 3La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 4Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Northstar Label Gabapentin Capsules, USP 300 mg Due to Complaints of Empty Capsules 2El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3
... ... Reportlinker.com announces that a new market research ... Fibrillation - Drug Pipeline Analysis and Market Forecasts to ... - Drug Pipeline Analysis and Market Forecasts to 2016 ...
... , , FRANKLIN, Mass. , ... Board: ECTE), a company developing the needle-free Symphony™ tCGM System ... and the Prelude™ SkinPrep System for transdermal drug delivery, announced ... Chairman and CEO, will be interviewed on " Steve Crowley ...
Cached Medicine Technology:Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016 2Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016 3Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016 4Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016 5Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016 6Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016 7Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016 8Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc. 2Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc. 3Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc. 4
(Date:11/24/2014)... Olaparib functions as a chemical of the compound ... the first PARP inhibitors. Sufferers with BRCA1/2 strains may ... and are often immune to other types of melanoma ... exclusive weaknesses, as the tissues of melanoma have improved ... them to proceed splitting. This implies that medication which ...
(Date:11/24/2014)... SWAccessControl.com has recently released a new collection ... the company is a leading online supplier in the international ... available at discounted prices, up to 30% off. , “We ... This time, all of our items are offered at low ... so I have confidence in our fresh assortment. You will ...
(Date:11/24/2014)... 2014 SafeHandles™ announced that they will ... Ed Begley Jr, airing via Discovery Channel. Dates and ... a passive, non-invasive, replaceable, and affordable germ protective device. ... shrinkable sleeves and adhesives to promote hand hygiene in ... core of SafeHandles is the desire to make a ...
(Date:11/24/2014)... California (PRWEB) November 24, 2014 Dr. ... Diego Fertility Center, recently appeared on NBC to discuss egg ... Egg freezing has been trending in the news recently, with ... expensive procedure for women. , “[The companies] see ... who are on a career hot path.” Says Dr. Kettel. ...
(Date:11/23/2014)... 24, 2014 iFitDress.com, a well-known wedding dress ... evening gowns . They are now offered at deeply ... will last from now to Dec. 15. The main purpose ... All the company’s high quality items are ideal options for ... large sum of money. All its new mint cocktail dresses ...
Breaking Medicine News(10 mins):Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 2Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 3Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 4Health News:SWAccessControl.com Is Happy To Release New Range Of Magnetic Locks 2Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2
... effective for inoperable liver cancer. It is a year since TheraSphere was ... ... either reducing tumour size or the number of tumours. Till date, it ... cannot be treated by any other means. ,TheraSphere involves injecting ...
... given to babies with low birth weight can significantly ... die from infectious diseases. The research involved 1,154 full-term ... India, most weighing 5 1/2 pounds or less. Mothers ... months. Fifteen of the 20 who died had not ...
... starting the day with a heavy breakfast and a steaming cup ... that women who eat fried food each morning are at ... oesophageal, cancer.The best way to reduce the incidence of cancer is ... or fruit. ,Cancer of the oesophagus - the food ...
... An enzyme involved in hormone production may help explain why ... their waist have such a high risk of heart disease ... approaches to treat obesity and its complications. // ... health problems such as heart disease and diabetes, but where ...
... who use stimulants like Ritalin are not at risk ... rats suggests that stimulant treatment in childhood may blunt ... ,Many children and teens with ADHD are treated ... appear to focus patients' attention and calm behavior. But ...
... than men to suffer brain cell damage from long-term use ... be reversed if they stop taking the drug. Studies have ... MDMA, can damage nerve endings that release serotonin, a brain ... also appears to damage brain cells that transmit nerve signals. ...
Cached Medicine News:Health News:Cut down on fries 2
... Stainless steel spiral reinforced. X-ray opaque . ... Flange: The flange can be adjusted along ... of the cervical soft tissue. The lock ... is tightly connected to the shaft. Maximum ...
Fome-Cuf® tubes can breathe with the patient to provide a safe, effective, and low pressure seal throughout the ventilatory cycle....
... tracheostomy tubes are available in both neonatal and ... an uncuffed tube, but it has a cuff. ... shaft of the tube. , ,TTS™ (tight-to-shaft) ... with the insurance of a cuff, if and ...
Indications For Usage: ,Bypass upper airway obstructions, provide long term ventilation, support and/or manage tracheal/bronchial secretions....
Medicine Products: